Marker Therapeutics, Inc.

Monthly Archives: April 2017

TapImmune Announces Change in Management and Board of Directors

TapImmune Inc. announced that on April 28,2017, Dr. John Bonfiglio resigned as Chief Operating Officer, President and director of TapImmune Inc. to pursue other opportunities.

Read More

Glynn Wilson – CEO of TapImmune on Vaccines for Cancer

Immunotherapy is the future of cancer treatment and TapImmune has been leading the charge. CEO Glynn Wilson discusses the advances made in the ovarian and breast cancer. The company is taking a vaccine approach to reduce recurrence of cancer and to improve progression free survival and in some cases to treat cancers that couldn’t otherwise be treated.

Read More